Skip to main content

APO 250 Pill - brown round, 11mm

Pill with imprint APO 250 is Brown, Round and has been identified as Gefitinib 250 mg.

Gefitinib is used in the treatment of Non Small Cell Lung Cancer and belongs to the drug class EGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Gefitinib 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for APO 250

Gefitinib

Imprint
APO 250
Strength
250 mg
Color
Brown
Size
11.00 mm
Shape
Round
Availability
Prescription only
Drug Class
EGFR inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Manufacturer
Apotex Corporation
National Drug Code (NDC)
60505-4512

Get help with Imprint Code FAQs.

Related images for "APO 250"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.